Whitepapers
Long Follow-Up in Short Supply
Whitepaper
Aug 5, 2024
Potential Impact of the IRA on the Generic Drug Market
Whitepaper
Jul 2, 2024
Patient Journey Empowerment: Realizing the potential for patients and your brand
Whitepaper
Dec 11, 2023
Competitive Planning and Response: Where to focus for sustained success
Whitepaper
Nov 22, 2023
Penetrating the CNS – Strategic Implications of an Increasingly Flexible FDA
Whitepaper
Nov 21, 2023
Cracking the Code: Unlocking Key Opinion Leaders in the Digital Landscape
Whitepaper
Nov 14, 2023
Half-time in the EU HTA Regulation Roll Out
In this whitepaper, published halfway through the European Union Health Technology Assessment Regulation preparatory phase running from January 2022 to January 2025, we summarize what we know of the EU HTA Regulation so far, and consider some of the uncertainties that remain.
Whitepaper
Sep 22, 2023
Before You Start the Strategic Planning Cycle: 5 essential things to streamline your approach
Whitepaper
Sep 11, 2023
ICER Value Assessment Framework Update 2023
Whitepaper
Aug 31, 2023
Advancing Clinical Development by Strategically Leveraging Advisory Boards
Whitepaper
Aug 11, 2023
CAR T-Cell Therapies in the US, UK and EU4
Whitepaper
Aug 8, 2023
Making a Case for Using Real World Data to Model Patient Entry in Budget Impact Analyses
Our team make the case for greater use of real world data (RWD) in modeling patient entry in budget impact analyses.
Whitepaper
Jul 13, 2023